Join Filyn Early Access
We’re inviting a select group of partners to experience Filyn before public launch, and directly shape the platform as it evolves.
What You’ll Get
For both Early Access and Design Partners:
-
Full use of the Filyn platform — now and in the future — at no cost
-
Priority access to every new capability before public release.
-
A direct voice in the roadmap, ensuring Filyn aligns with your workflows.
-
Guided onboarding and priority support from our team
-
Option to be publicly acknowledged (or remain confidential) as a partner
Who Should Join
If you work on taking science to submission, you belong here:
- Regulatory leaders: Regulatory Affairs, RegOps (biotech & pharma)
- Technical leads & writers: CMC, nonclinical, medical–regulatory writers
- Quality & compliance: QA/QC, compliance specialists
- Services & consulting: CRO teams, regulatory consultants/advisors
- Program owners: Founders, program leads preparing a first IND
Why It’s Worth Your Time
- Save hours immediately: Get structured outlines, usable summaries, and auto-mapped IND sections from day one.
- Stay in control: All AI outputs are drafts for your expert review, with version history, comments, and full audit trail.
- Shape the platform: Your input drives core features — section mapping, gap analysis, validation checks, regulator engagement.
- Secure by design: Private by default • NDA available • Encryption in transit & at rest • Delete data anytime
Two Ways to Join
Early Access — Quick Start
- For teams who want to explore Filyn and see the benefits right away.
-
Your role: try it, use it, and share your impressions.
Design Partner — Shape the Future
- For teams who want to collaborate more closely on Filyn’s evolution.
- Your role: stay engaged, give feedback, and guide what we build next.
Get Started
Please complete the short enrollment form — we’ll confirm your place and guide you through setup.
We welcome new participants in small groups so we can give you hands-on support and incorporate your feedback quickly.
All features and capabilities are provided for evaluation purposes only and may change prior to general availability. Filyn does not provide regulatory, legal, or clinical advice. Any AI-generated content is draft material intended to assist qualified experts and must be reviewed and validated prior to inclusion in regulatory submissions. Filyn is provided ‘as is’ without warranties of any kind, and we disclaim liability for any errors, omissions, or outcomes arising from reliance on the platform or its outputs.